サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390554

オルソバイオロジクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Orthobiologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
オルソバイオロジクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

オルソバイオロジクスの世界市場規模は2022年に57億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに77億米ドルに達し、2022～2028年の成長率（CAGR）は5.14%になると予測しています。

オルソバイオロジクスは、炭水化物、タンパク質、細胞、糖タンパク質など、体内に自然に存在する物質を用いて作られる組織由来の製品です。痛みや炎症を抑え、変形性関節症の衰弱を回復させ、軟骨再生、腱治癒、靭帯修復、骨形成のプロセスを促進します。一般的に利用されている整形生物学的療法には、幹細胞、多血小板血漿（PRP）、自家調整血漿（ACP）、骨髄吸引濃縮液（BMAC）などがあります。その中でもPRPは、様々な筋骨格系の疾患において、副作用の少ない新しい治療法として世界中で支持を集めています。これらの疾患には、腱板断裂、肩峰下インピンジメント、変形性肩関節症、膝蓋腱症、外側上顆腱症、変形性膝関節症などが含まれます。

オルソバイオロジクスの市場動向：

オルソバイオロジクスは、プロやレクリエーションのスポーツ選手のスポーツ関連傷害の早期回復を助ける。スポーツや身体活動への市場参入企業の増加は、市場にプラスの影響を与える主な要因の1つです。これとは別に、腱板断裂は身体の退行性変化により高齢者の間で現れることがあります。これは、高齢者人口の増加と相まって、市場の成長を促しています。さらに、座りっぱなしのライフスタイル、不健康な食事パターン、慢性疾患の蔓延により、変形性関節症の発症リスクが高まる可能性があります。加えて、侵襲的な手術に利用されるいくつかのオルソバイオロジクスは、保険適用で払い戻しが可能であり、これが市場の成長を強化しています。さらに、人工関節置換術のような大きな侵襲を伴う手術の回避や回復時間の短縮など、生物学的矯正療法に関連する利点に対する意識の高まりが、他の外科手術よりもその採用を促進しています。これに加えて、整形外科手術の増加や骨折固定用の生体吸収性インプラントに対する需要の高まりが、小児人口における自家骨移植片や同種移植片、脱灰骨マトリックスなどのオルソバイオロジクスの使用に寄与しています。

本レポートで扱う主な質問

  • オルソバイオロジクスの世界市場はこれまでどのように推移してきたか？
  • COVID-19が世界のオルソバイオロジクス市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • タイプ別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のオルソバイオロジクス市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 オルソバイオロジクスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 脱灰骨マトリックス
    • 市場動向
    • 市場予測
  • 同種移植片
    • 市場動向
    • 市場予測
  • 骨形成タンパク質
    • 市場動向
    • 市場予測
  • 関節内補充療法製品
    • 市場動向
    • 市場予測
  • 合成骨補填剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：タイプ別

  • 膝
    • 市場動向
    • 市場予測
  • 足首
    • 市場動向
    • 市場予測
  • 股関節
    • 市場動向
    • 市場予測
  • 手首と肩
    • 市場動向
    • 市場予測
  • 脊椎
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 変形性関節症と変性関節症
    • 市場動向
    • 市場予測
  • 脊椎固定術
    • 市場動向
    • 市場予測
  • 骨折回復
    • 市場動向
    • 市場予測
  • 軟部組織損傷
    • 市場動向
    • 市場予測
  • 顎顔面および歯科用途
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院と外来センター
    • 市場動向
    • 市場予測
  • 研究・学術機関
    • 市場動向
    • 市場予測
  • 歯科医院・施設
    • 市場動向
    • 市場予測
  • 整形外科クリニック
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Arthrex Inc
    • Globus Medical Inc.
    • Integra LifeSciences
    • Johnson & Johnson
    • Medline Industries Inc.
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
    • Wright Medical Group N.V.
    • Zimmer Biomet
図表

List of Figures

  • Figure 1: Global: Orthobiologics Market: Major Drivers and Challenges
  • Figure 2: Global: Orthobiologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Orthobiologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Orthobiologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Orthobiologics Market: Breakup by Type (in %), 2022
  • Figure 6: Global: Orthobiologics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Orthobiologics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Orthobiologics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Orthobiologics (Demineralized Bone Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Orthobiologics (Demineralized Bone Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Orthobiologics (Allograft) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Orthobiologics (Allograft) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Orthobiologics (Bone Morphogenetic Protein) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Orthobiologics (Bone Morphogenetic Protein) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Orthobiologics (Viscosupplementation Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Orthobiologics (Viscosupplementation Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Orthobiologics (Synthetic Bone Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Orthobiologics (Synthetic Bone Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Orthobiologics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Orthobiologics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Orthobiologics (Knee) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Orthobiologics (Knee) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Orthobiologics (Ankle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Orthobiologics (Ankle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Orthobiologics (Hip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Orthobiologics (Hip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Orthobiologics (Wrist and Shoulder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Orthobiologics (Wrist and Shoulder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Orthobiologics (Spine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Orthobiologics (Spine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Orthobiologics (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Orthobiologics (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Orthobiologics (Spinal Fusion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Orthobiologics (Spinal Fusion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Orthobiologics (Fracture Recovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Orthobiologics (Fracture Recovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Orthobiologics (Soft Tissue Injuries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Orthobiologics (Soft Tissue Injuries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Orthobiologics (Maxillofacial and Dental Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Orthobiologics (Maxillofacial and Dental Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Orthobiologics (Research and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Orthobiologics (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Orthobiologics (Dental Clinics and Facilities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Orthobiologics (Dental Clinics and Facilities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Orthobiologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Orthobiologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: North America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: North America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United States: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United States: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Canada: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Canada: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Asia-Pacific: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Asia-Pacific: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: China: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: China: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Japan: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Japan: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: India: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: India: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: South Korea: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: South Korea: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Australia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Australia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Indonesia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Indonesia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Europe: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Germany: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Germany: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: France: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: France: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: United Kingdom: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: United Kingdom: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Italy: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Italy: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Spain: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Spain: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Russia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Russia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Latin America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Latin America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Brazil: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Brazil: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Mexico: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Mexico: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Middle East and Africa: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Middle East and Africa: Orthobiologics Market: Breakup by Country (in %), 2022
  • Figure 99: Middle East and Africa: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Global: Orthobiologics Industry: SWOT Analysis
  • Figure 101: Global: Orthobiologics Industry: Value Chain Analysis
  • Figure 102: Global: Orthobiologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Orthobiologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Orthobiologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Orthobiologics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 4: Global: Orthobiologics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Orthobiologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Orthobiologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Orthobiologics Market: Competitive Structure
  • Table 8: Global: Orthobiologics Market: Key Players
目次
Product Code: SR112023A4332

Abstract

The global orthobiologics market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.14% during 2022-2028.

Orthobiologics are tissue-derived products made using substances that are naturally found in the body, such as carbohydrates, proteins, cells, and glycoproteins. They assist in reducing pain and inflammation, reversing debilitating effects of osteoarthritis, and facilitating the process of cartilage regeneration, tendon healing, ligament repairing, and bone formation. Some of the commonly utilized orthobiologic therapies are stem cells, platelet-rich plasma (PRP), autologous conditioned plasma (ACP), and bone marrow aspirate concentrate (BMAC). Amongst these, PRP is gaining traction across the globe as novel treatment modalities with minimal side effects in diverse musculoskeletal conditions. These conditions include rotator cuff tears, sub-acromial impingement, shoulder osteoarthritis, patellar tendinosis, lateral epicondylar tendinopathy, and knee osteoarthritis.

Orthobiologics Market Trends:

Orthobiologics aid in the quick recovery of sports-related injuries among professional and recreational athletes. The increasing participation of individuals in sports and physical activities represents one of the major factors influencing the market positively. Apart from this, rotator cuff tears can appear among older people due to degenerative changes in the body. This, in confluence with the growing geriatric population, is impelling the market growth. Moreover, the risk of developing osteoarthritis can be increased due to sedentary lifestyles, unhealthy dietary patterns, and the prevalence of chronic diseases. In addition, several orthobiologics utilized for invasive surgeries can be reimbursed under insurance coverage, which is strengthening the market growth. Furthermore, the growing awareness about the benefits associated with orthobiologic therapies, such as avoiding major invasive surgery like joint replacement and fast recovery time, is promoting their adoption over other surgical procedures. Besides this, the increasing number of orthopedic surgeries and the escalating demand for bioabsorbable implants for fracture fixation is contributing to the use of orthobiologics, such as autograft and allograft bone, and demineralized bone matrix, among the pediatric population.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global orthobiologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, application and end user.

Breakup by Product:

Demineralized Bone Matrix

Allograft

Bone Morphogenetic Protein

Viscosupplementation Products

Synthetic Bone Substitutes

Others

Breakup by Type:

Knee

Ankle

Hip

Wrist and Shoulder

Spine

Others

Breakup by Application:

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Fracture Recovery

Soft Tissue Injuries

Maxillofacial and Dental Applications

Breakup by End User:

Hospitals and Ambulatory Centers

Research and Academic Institutes

Dental Clinics and Facilities

Orthopedic Clinics

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report:

  • How has the global orthobiologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global orthobiologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global orthobiologics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Orthobiologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Demineralized Bone Matrix
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Allograft
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bone Morphogenetic Protein
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Viscosupplementation Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Synthetic Bone Substitutes
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Knee
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ankle
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hip
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wrist and Shoulder
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Spine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Osteoarthritis and Degenerative Arthritis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Spinal Fusion
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Fracture Recovery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Soft Tissue Injuries
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Maxillofacial and Dental Applications
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Ambulatory Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research and Academic Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Dental Clinics and Facilities
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Orthopedic Clinics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Arthrex Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Globus Medical Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Integra LifeSciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Medline Industries Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Medtronic plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 NuVasive Inc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Orthofix Medical Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Smith & Nephew plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Stryker Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wright Medical Group N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 Zimmer Biomet
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis